Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- Duke University
- Study ID
- NCT06972719
- Status
- Recruiting
Conditions
- BRCA1 Mutation
- BRCA2 Mutation
Eligibility Criteria
- Sex
- FEMALE
- Age
- 19 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Experimental Arm — BEHAVIORALParticipants will be randomized to SOC plus the video.
- SOC Arm — BEHAVIORALParticipants will be randomized to SOC counseling.
Study Details
The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).
Key Dates
- First listed
- May 15, 2025
- Start date
- Sep 30, 2025
- Status verified
- Aug 2025
- Primary completion
- Jul 1, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Placebo Comparator: Standard of CareThe control arm will receive standard counseling regarding post operative HRT by their gynecologic oncologist during their visit, as well as standardized written education in their after-visit summary.
- Experimental: ExperimentalThe experimental arm will receive standard verbal counseling and written education plus the video-based educational aid describing the risks and benefits of HRT.
Primary Outcome Measure
Decisional Conflict pre-randomization [ Time Frame: Baseline, pre-randomization ]
Central Contacts
- Amelia Scott(919) 613-4584
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UNC Chapel Hill Health System | Chapel Hill | North Carolina | 27514 | Katherine Tucker, MD (PRINCIPAL_INVESTIGATOR) |
| Duke University Health System | Durham | North Carolina | 27710 | Laura Havrilesky, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Chapel Hill, NC
Related Studies
- Genetic Education in BRCA FamiliesEnrolling By Invitation · Georgetown University · Washington D.C., District of Columbia
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsPHASE1 · Recruiting · General Oncology, Inc. · New York, New York
- Prostate Cancer Genetic Risk Evaluation and Screening StudyRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test ResultsRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey